Swiss Industries in Turmoil: The U.S. Tariff Hike Impact
The U.S. has imposed a 39% tariff on Swiss exports, surpassing the previously expected rate. This levy threatens tens of thousands of Swiss jobs, especially impacting pharmaceuticals, watches, and machinery. While negotiations continue, the Swiss economy braces for weakened growth, as the U.S. demands trade concessions.

Swiss manufacturers have been warned that tens of thousands of jobs are at risk following President Donald Trump's decision to impose a 39% tariff on Swiss exports. This move marks a drastic increase from the expected 31%, outpacing the general 15% rate applied to most European Union imports.
The Swiss government has expressed disappointment over the tariffs, which significantly impact the country's export-reliant economy, notably in sectors such as pharmaceuticals, watches, machinery, and chocolates. While Swiss officials remain open to dialogue, there is limited room for concessions due to existing free market access for U.S. imports.
Despite exemptions for the pharmaceuticals sector, uncertainties loom as a national security investigation could lead to additional tariffs. The threat reverberates through interconnected global supply chains, potentially impacting vital medication supplies, amidst ongoing negotiations between Switzerland and the U.S.
(With inputs from agencies.)
ALSO READ
India Reinforces Stance Against Patent Evergreening Amid Global Trade Talks
EU-US Forge Strategic Zero-Tariff Agreement Amid Global Trade Tensions
Global Trade Friction Eases After U.S.-EU Agreement
SA Defence Firms Return from IDEF 2025 with Major Global Trade Leads
Global Trade Deal Boosts Stocks Amid Crucial Policy Week